Nephrolithiasis associated with embolization material, Lipiodol®, following embolization of large renal angiomyolipoma

Angiomyolipoma (AML) is a benign renal mass that can be treated with nephron sparing surgery or transarterial embolization. Embolization has been favored due to efficacy and safety profile. This case demonstrates a previously undocumented phenomenon of AML treated with transarterial embolization usi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Irene Chen, Sara Q. Perkins, Scott E. Schwartz, David Leavitt
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2022
Materias:	Angiomyolipoma Endourology Embolization Lipiodol® Renal mass Interventional radiology Diseases of the genitourinary system. Urology RC870-923
Acceso en línea:	https://doaj.org/article/21904c359b444a918311f8eab5d1abe3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:21904c359b444a918311f8eab5d1abe3
record_format	dspace
spelling	oai:doaj.org-article:21904c359b444a918311f8eab5d1abe32021-11-04T04:31:11ZNephrolithiasis associated with embolization material, Lipiodol®, following embolization of large renal angiomyolipoma2214-442010.1016/j.eucr.2021.101910https://doaj.org/article/21904c359b444a918311f8eab5d1abe32022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2214442021003508https://doaj.org/toc/2214-4420Angiomyolipoma (AML) is a benign renal mass that can be treated with nephron sparing surgery or transarterial embolization. Embolization has been favored due to efficacy and safety profile. This case demonstrates a previously undocumented phenomenon of AML treated with transarterial embolization using Lipiodol® (Guerbet LLC, Princeton, NJ) resulting in nephrolithiasis and retention of Lipiodol® two years after original embolization. Although Lipiodol®-based embolization has not been shown to cause nephrolithiasis, it may have been the nidus for stone formation, and this is an important potential complication worthy of further study.Irene ChenSara Q. PerkinsScott E. SchwartzDavid LeavittElsevierarticleAngiomyolipomaEndourologyEmbolizationLipiodol®Renal massInterventional radiologyDiseases of the genitourinary system. UrologyRC870-923ENUrology Case Reports, Vol 40, Iss , Pp 101910- (2022)
institution	DOAJ
collection	DOAJ
language	EN
topic	Angiomyolipoma Endourology Embolization Lipiodol® Renal mass Interventional radiology Diseases of the genitourinary system. Urology RC870-923
spellingShingle	Angiomyolipoma Endourology Embolization Lipiodol® Renal mass Interventional radiology Diseases of the genitourinary system. Urology RC870-923 Irene Chen Sara Q. Perkins Scott E. Schwartz David Leavitt Nephrolithiasis associated with embolization material, Lipiodol®, following embolization of large renal angiomyolipoma
description	Angiomyolipoma (AML) is a benign renal mass that can be treated with nephron sparing surgery or transarterial embolization. Embolization has been favored due to efficacy and safety profile. This case demonstrates a previously undocumented phenomenon of AML treated with transarterial embolization using Lipiodol® (Guerbet LLC, Princeton, NJ) resulting in nephrolithiasis and retention of Lipiodol® two years after original embolization. Although Lipiodol®-based embolization has not been shown to cause nephrolithiasis, it may have been the nidus for stone formation, and this is an important potential complication worthy of further study.
format	article
author	Irene Chen Sara Q. Perkins Scott E. Schwartz David Leavitt
author_facet	Irene Chen Sara Q. Perkins Scott E. Schwartz David Leavitt
author_sort	Irene Chen
title	Nephrolithiasis associated with embolization material, Lipiodol®, following embolization of large renal angiomyolipoma
title_short	Nephrolithiasis associated with embolization material, Lipiodol®, following embolization of large renal angiomyolipoma
title_full	Nephrolithiasis associated with embolization material, Lipiodol®, following embolization of large renal angiomyolipoma
title_fullStr	Nephrolithiasis associated with embolization material, Lipiodol®, following embolization of large renal angiomyolipoma
title_full_unstemmed	Nephrolithiasis associated with embolization material, Lipiodol®, following embolization of large renal angiomyolipoma
title_sort	nephrolithiasis associated with embolization material, lipiodol®, following embolization of large renal angiomyolipoma
publisher	Elsevier
publishDate	2022
url	https://doaj.org/article/21904c359b444a918311f8eab5d1abe3
work_keys_str_mv	AT irenechen nephrolithiasisassociatedwithembolizationmateriallipiodolfollowingembolizationoflargerenalangiomyolipoma AT saraqperkins nephrolithiasisassociatedwithembolizationmateriallipiodolfollowingembolizationoflargerenalangiomyolipoma AT scotteschwartz nephrolithiasisassociatedwithembolizationmateriallipiodolfollowingembolizationoflargerenalangiomyolipoma AT davidleavitt nephrolithiasisassociatedwithembolizationmateriallipiodolfollowingembolizationoflargerenalangiomyolipoma
_version_	1718445258449092608

Nephrolithiasis associated with embolization material, Lipiodol®, following embolization of large renal angiomyolipoma

Ejemplares similares